Alzheimer’s disease

Leon Cai explains his poster to Sharon Kam (center) and Katherine Lee at the 2022 Alzheimer’s Disease Research Day.

Event highlights research on Alzheimer’s disease

The third annual Vanderbilt Alzheimer’s Disease Research Day featured numerous presentations and concluded with a keynote address by Suzanne Craft, PhD, director of the Alzheimer’s Disease Research Center at Wake Forest University.

PET imaging probe for Alzheimer’s disease

Vanderbilt researchers report on a new PET imaging probe that will be useful for exploring Alzheimer’s disease pathology.

Vanderbilt Kennedy Center to host Jan. 25 workshop on Down syndrome and Alzheimer’s disease

PHOTO: Members of the supermere discovery team include (front row from left) Qi Liu, PhD, Robert Coffey, MD, Qin Zhang, PhD, and (back row from left) James Higginbotham, PhD; Dennis Jeppesen, PhD; and Jeffrey Franklin, PhD. (hoto by Erin O. Smith)

“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19

Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.

Vanderbilt voices featured in Alzheimer’s webcast

Vanderbilt researchers took part in an online panel discussion this week sponsored by the Women’s Alzheimer’s Movement (WAM), hosted by journalist and author Maria Shriver, the organization’s founder, and NBC news anchor Richard Lui.

VUMC awarded $31.7 million to harmonize Alzheimer’s research data

Vanderbilt University Medical Center has received a $31.7 million federal grant to harmonize research data gathered on human subjects in scores of disparate studies of Alzheimer’s disease and related dementias.

1 2 3 4 7